Review
doi: 10.1016/s1074-7613(00)80366-0.
The emerging role of CTLA-4 as an immune attenuator
Affiliations
- PMID: 9354465
- DOI: 10.1016/s1074-7613(00)80366-0
Item in Clipboard
Review
The emerging role of CTLA-4 as an immune attenuator
Immunity.
1997 Oct.
Free article
No abstract available
Similar articles
-
Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation?J Exp Med. 1995 Aug 1;182(2):289-92. doi: 10.1084/jem.182.2.289. J Exp Med. 1995. PMID: 7543133 Free PMC article. Review. No abstract available.
-
The CD28-B7 costimulatory pathway and its role in autoimmune disease.J Leukoc Biol. 1997 Aug;62(2):156-62. doi: 10.1002/jlb.62.2.156. J Leukoc Biol. 1997. PMID: 9261329 Review.
-
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.J Exp Med. 1995 Aug 1;182(2):459-65. doi: 10.1084/jem.182.2.459. J Exp Med. 1995. PMID: 7543139 Free PMC article.
-
CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.Res Immunol. 1995 Mar-Apr;146(3):130-40. doi: 10.1016/0923-2494(96)80246-x. Res Immunol. 1995. PMID: 8525042 Review. No abstract available.
-
B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.J Immunol. 2001 Aug 1;167(3):1830-8. doi: 10.4049/jimmunol.167.3.1830. J Immunol. 2001. PMID: 11466409
Cited by
-
Down-regulation of epithelial IL-8 responses in Helicobacter pylori-infected duodenal ulcer patients depends on host factors, rather than bacterial factors.Clin Exp Immunol. 2005 Apr;140(1):117-25. doi: 10.1111/j.1365-2249.2005.02736.x. Clin Exp Immunol. 2005. PMID: 15762883 Free PMC article.
-
The concept of space and competition in immune regulation.Immunology. 2004 Mar;111(3):241-7. doi: 10.1111/j.1365-2567.2004.01831.x. Immunology. 2004. PMID: 15009422 Free PMC article. Review. No abstract available.
-
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15074-9. doi: 10.1073/pnas.96.26.15074. Proc Natl Acad Sci U S A. 1999. PMID: 10611340 Free PMC article.
-
Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor.Onco Targets Ther. 2019 Nov 11;12:9527-9538. doi: 10.2147/OTT.S224013. eCollection 2019. Onco Targets Ther. 2019. PMID: 31807028 Free PMC article. Review.
-
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.Ann Surg Oncol. 2005 Dec;12(12):1005-16. doi: 10.1245/ASO.2005.03.536. Epub 2005 Oct 21. Ann Surg Oncol. 2005. PMID: 16283570 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
